Treatment Adherence and Quality of Life in Patients on Antihypertensive Medication in Southern Rajasthan Population
- 1. Assistant professor, Department of General Medical, Pacific Medical College & Hospital, Udaipur
Description
Background: The purpose of this study is to evaluate medication adherence in hypertensive patients. Method and Materials: Participants in this observational, cross-sectional study had hypertension for the previous year and were treated in the Department of Medicine Pacific Medical College & Hospital, Udaipur. Hypertensive outpatients under the age of 18 were the focus of the study. A method known as systemic sampling was used to find people to participate. A definite history, careful clinical assessment, and guiding for way of life changes was finished on all members selected. Patients were given the WHO-QOL Bref and Morisky Medication Adherence Scale-8 (MMAS-8) questionnaires to fill out in a separate room. Results: 152 patients participated in the study, with a mean MMAS-8 Score of 4.88±1.10 and a mean number of medications taken per person of 1.680.79. Seventy-four percent of patients were taking a combination of medications. Group 1 (on a single medication) and Group 2 (on two or more medications) were the two groups of participants. Better quality of life and significantly higher MMAS-8 scores were found in Group 1. Conclusion: Compared to patients on more than two medications, those on a single medication had significantly better adherence, slightly better quality of life, and better adherence correlation.
Abstract (English)
Background: The purpose of this study is to evaluate medication adherence in hypertensive patients. Method and Materials: Participants in this observational, cross-sectional study had hypertension for the previous year and were treated in the Department of Medicine Pacific Medical College & Hospital, Udaipur. Hypertensive outpatients under the age of 18 were the focus of the study. A method known as systemic sampling was used to find people to participate. A definite history, careful clinical assessment, and guiding for way of life changes was finished on all members selected. Patients were given the WHO-QOL Bref and Morisky Medication Adherence Scale-8 (MMAS-8) questionnaires to fill out in a separate room. Results: 152 patients participated in the study, with a mean MMAS-8 Score of 4.88±1.10 and a mean number of medications taken per person of 1.680.79. Seventy-four percent of patients were taking a combination of medications. Group 1 (on a single medication) and Group 2 (on two or more medications) were the two groups of participants. Better quality of life and significantly higher MMAS-8 scores were found in Group 1. Conclusion: Compared to patients on more than two medications, those on a single medication had significantly better adherence, slightly better quality of life, and better adherence correlation.
Files
IJTPR,Vol12,Issue8,Article45.pdf
Files
(297.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:22b0c97ca74ebba370ccc09903ea7a76
|
297.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-08-01
Software
References
- 1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217–223. 2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population- based studies from 90 countries. Circulation. 2016; 134:441–450 3. Lindenfeld J, Jessup M. 'Drugs don't work in patients who don't take them' (C. Everett Koop, MD, US Surgeon General, 1985). Eur J Heart Fail. 2017; 19:1412–1413. 4. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002; 288:2868–2879. 5. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223- 237. 6. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014 Jun;32(6):1170-7. 7. World Health Organization. Prevention of cardiovascular disease. Pocket guidelines for assessment and management of cardiovascular risk. WHO Press 2007. Available at url: ishworld.com/downloads/activities/Poc ket GL_ENGLISH_A FR_DE_rev1.pdf 8. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: Role of illness perception and treatment beliefs. Journal of Human Hypertension 2004; 18:607-13. 9. Alhadad IA, Hamoui O, Hammoudeh A, Mallat S. Treatment adherence and quality of life in patients on antihypertensive medication in a Middle East population: Adherence. Vascular Health and Risk Management 2016; 12:407-13. 10. Amaral O, Chaves C, Duarte J, Coutinho E, Nelas P, Preto O. Treatment adherence in hypertensive patients – A cross sectional study. Procedia-Social and Behavioral Sciences 2015; 171:1288-95. 11. Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Gulsin GS, et al. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence. Hypertension. 2017 Nov;70(5):1042- 1048. 12. Meinema JG, van Dijk N, Beune EJAJ, Jaarsma DADC, van Weart HCPM, Haafkens JA. Determinants of adherence to treatment in hypertensive patients of African Descent and role of culturally appropriate education. PLoS ONE 2015;10(8): e0133560. 13. Gupta R, Guptha S. Strategies for initial management of hypertension. Indian J Med Res 2010; 132:531-42. 14. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et.al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (CardioSis): An open-label randomized trial. Lancet 2009;374(9689):525-33. 15. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: Role of illness perception and treatment beliefs. Journal of Human Hypertension 2004; 18:607-13. 16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–52.